Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · IEX Real-Time Price · USD
1,063.60
-3.66 (-0.34%)
At close: Jul 19, 2024, 4:00 PM
1,081.87
+18.27 (1.72%)
Pre-market: Jul 22, 2024, 7:29 AM EDT
Regeneron Pharmaceuticals Employees
Regeneron Pharmaceuticals had 13,450 employees as of December 31, 2023. The number of employees increased by 1,599 or 13.49% compared to the previous year.
Employees
13,450
Change (1Y)
1,599
Growth (1Y)
13.49%
Revenue / Employee
$973,985
Profits / Employee
$286,825
Market Cap
115.26B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 13,450 | 1,599 | 13.49% |
Dec 31, 2022 | 11,851 | 1,483 | 14.30% |
Dec 31, 2021 | 10,368 | 1,245 | 13.65% |
Dec 31, 2020 | 9,123 | 1,023 | 12.63% |
Dec 31, 2019 | 8,100 | 700 | 9.46% |
Dec 31, 2018 | 7,400 | 1,200 | 19.35% |
Dec 31, 2017 | 6,200 | 800 | 14.81% |
Dec 31, 2016 | 5,400 | 1,100 | 25.58% |
Dec 31, 2015 | 4,300 | 1,375 | 47.01% |
Dec 31, 2014 | 2,925 | 585 | 25.00% |
Dec 31, 2013 | 2,340 | 390 | 20.00% |
Dec 31, 2012 | 1,950 | 246 | 14.44% |
Dec 31, 2011 | 1,704 | 309 | 22.15% |
Dec 31, 2010 | 1,395 | 366 | 35.57% |
Dec 31, 2009 | 1,029 | 110 | 11.97% |
Dec 31, 2008 | 919 | 237 | 34.75% |
Dec 31, 2007 | 682 | 109 | 19.02% |
Dec 31, 2006 | 573 | -15 | -2.55% |
Dec 31, 2005 | 588 | -142 | -19.45% |
Dec 31, 2004 | 730 | 86 | 13.35% |
Dec 31, 2003 | 644 | -25 | -3.74% |
Dec 31, 2002 | 669 | 94 | 16.35% |
Dec 31, 2001 | 575 | 84 | 17.11% |
Dec 31, 2000 | 491 | 54 | 12.36% |
Dec 31, 1999 | 437 | 66 | 17.79% |
Dec 31, 1998 | 371 | 101 | 37.41% |
Dec 31, 1997 | 270 | 27 | 11.11% |
Dec 31, 1996 | 243 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Elevance Health | 104,900 |
Medtronic | 95,000 |
Sanofi | 86,088 |
Cigna | 72,500 |
Boston Scientific | 48,000 |
Bristol-Myers Squibb Company | 34,100 |
Stryker | 26,700 |
Gilead Sciences | 18,000 |
REGN News
- 2 days ago - Regeneron Pharmaceuticals Incorporated Investors With Losses Are Encouraged By The Schall Law Firm To Reach Out Amidst Initiation Of An Allegations Investigation - Accesswire
- 3 days ago - Investors Of Regeneron Pharmaceuticals Incorporated With Losses Are Urged To Connect As The Schall Law Firm Begins An Investigation Into Allegations - Accesswire
- 4 days ago - Regeneron Pharmaceuticals Inc Investors With Losses Are Invited To Reach Out As The Schall Law Firm Begins An Investigation Into Allegations - Accesswire
- 8 days ago - Investors Of Regeneron Pharmaceuticals Inc With Losses Are Encouraged To Contact As The Schall Law Firm Initiates A Probe Into Claims - Accesswire
- 9 days ago - Regeneron Pharmaceuticals Inc Investors With Losses Are Urged To Reach Out As The Schall Law Firm Begins An Investigation Into Allegations - Accesswire
- 10 days ago - Investors With Losses Are Encouraged To Contact As The Schall Law Firm Initiates An Investigation Into Claims Against Regeneron Pharmaceuticals Inc - Accesswire
- 11 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN - PRNewsWire
- 11 days ago - Regeneron Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire